Đan Mạch -
Tiếng Đan Mạch -
Lægemiddelstyrelsen (Danish Medicines Agency)
spirix 25 mg tabletter
orifarm healthcare a/s - spironolacton - tabletter - 25 mg
Đan Mạch -
Tiếng Đan Mạch -
Lægemiddelstyrelsen (Danish Medicines Agency)
spirix 100 mg tabletter
orifarm healthcare a/s - spironolacton - tabletter - 100 mg
Đan Mạch -
Tiếng Đan Mạch -
Lægemiddelstyrelsen (Danish Medicines Agency)
spirix 50 mg tabletter
orifarm healthcare a/s - spironolacton - tabletter - 50 mg
Đan Mạch -
Tiếng Đan Mạch -
Lægemiddelstyrelsen (Danish Medicines Agency)
montelukast "accord healthcare" 10 mg filmovertrukne tabletter
accord healthcare b.v. - montelukastnatrium - filmovertrukne tabletter - 10 mg
Đan Mạch -
Tiếng Đan Mạch -
Lægemiddelstyrelsen (Danish Medicines Agency)
lenalidomid "helm ag" 2,5 mg kapsler, hårde
helm ag - lenalidomid - kapsler, hårde - 2,5 mg
Đan Mạch -
Tiếng Đan Mạch -
Lægemiddelstyrelsen (Danish Medicines Agency)
magnyl "dak" 100 mg enterotabletter
orifarm healthcare a/s - acetylsalicylsyre - enterotabletter - 100 mg
Liên Minh Châu Âu -
Tiếng Đan Mạch -
EMA (European Medicines Agency)
clopidogrel acino
acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotiske midler - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.